Karim Lalji

Karim Lalji is the current Chairman at Sitka Biopharma. Karim has over 25 years of experience in the pharmaceutical industry. Prior to joining Sitka, they were the Vice President of Business Strategy and New Product Commercialization at Sepracor from July 2000 to February 2007. Before that, they were the Worldwide Marketing Director (FOSAMAX, CRIXIVAN) and Director of Business Strategy at Merck from September 1991 to July 2000.

Karim Lalji's educational career includes a Social Media degree from Harvard University in Health Policy & Management/Business Administration and a BBA from Simon Fraser University in Marketing.